AstraZeneca has announced the appointment of two new Non-Executive Directors.

The former CEO of Avon, Sheri McCoy will join at the start of October. McCoy will also become member of the Audit Committee.

Meanwhile, Global GM for IBM Watson Health, Deborah DiSanzo will take up her role from December.

“We are delighted to welcome Sheri McCoy and Deborah DiSanzo to our Board. They are proven, seasoned executive leaders with experience and knowledge directly relevant to AstraZeneca’s business – Sheri’s deep understanding of the pharmaceutical business from her many years at Johnson & Johnson and Deborah’s distinguished career in healthcare and technology with IBM Watson Health and previously Philips Healthcare. We look forward to their contributions to the work of the Board of AstraZeneca,” said Leif Johansson, Chairman.